Nadja Mannowetz net worth
Quick answer
Nadja Mannowetz's estimated net worth is $14.0M (range $9.8M – $21.0M) as of 2026. Nadja Mannowetz is Founder at YourChoice Therapeutics. YourChoice Therapeutics valuation.
Nadja Mannowetz is Founder at YourChoice Therapeutics (YC W19). Independent Entrepreneurial Check model estimate from public YC data.
At a glance
- Company status: Active
- Education: Stanford University
- Region: United States of America
- Industries: Healthcare, Therapeutics
- Team size: 3
- Website: http://ychoicetx.com
Who is Nadja Mannowetz?
Nadja Mannowetz is a founder at YourChoice Therapeutics, which participated in Y Combinator's W19 batch.
Highlights:
- Stanford University
- Y Combinator
About YourChoice Therapeutics
YourChoice Therapeutics is revolutionizing the global contraceptive market. Our vision is to develop non-hormonal contraceptives to provide both women and men with birth control options that lack the associated risks of hormone-based options but are equally effective. Traditionally, it has been the women’s financial and health burden to have a contraceptive in place. Our first goal is therefore to bring a novel...
FAQ: Nadja Mannowetz net worth and YourChoice Therapeutics valuation
What is Nadja Mannowetz's net worth?
Nadja Mannowetz's estimated net worth is $14.0M (range $9.8M – $21.0M) as of 2026. Nadja Mannowetz is Founder at YourChoice Therapeutics. Entrepreneurial Check publishes an independent model-based estimate from public company and role data. Not verified net worth, and Entrepreneurial Check is not affiliated with Y Combinator or the profiled companies.
What is YourChoice Therapeutics valuation?
YourChoice Therapeutics's estimated valuation on Entrepreneurial Check is $150.0M. That valuation, or a disclosed round when one is public, is the source for the paper-wealth estimate. Independent model output — not a verified appraisal or official mark.
What is Nadja Mannowetz's role?
Nadja Mannowetz is Founder at YourChoice Therapeutics, a Y Combinator-backed startup (batch W19).